Skip to main content
. 2020 Jun 4;41(3):571–576. doi: 10.1038/s41372-020-0703-4

Table 2.

Demographics and preoperative comorbidities of prolonged and short-no intubation groups.

Variable PIG SNIG p
Adjusted age at time of surgery 41.8 Weeks 42.0 Weeks 0.53
Weight at time of surgery 3.2 kg 3.1 kg 0.08
PHT 6 (21.4%) 4 (7.0%) 0.07
BPD 23 (82.1%) 32 (56.1%) 0.03
RDS 22 (84.6%) 39 (68.4%) 0.18
ORP 23 (82.1%) 35 (61.4%) 0.08
Major CHD 4 (14.3%) 3 (5.3%) 0.21
Minor CHD 23 (82.1%) 44 (77.2%) 0.78
Prior intubation 26 (92.9%) 41 (73.2%) 0.04
Muscle relaxants use 2 (7.7%) 11 (23.4%) 0.12
Opioid use 27 (96.4%) 47 (82.5%) 0.09
Neonatal apnea 20 (71.4%) 39 (68.4%) 1.00
Ongoing apnea 19 (67.9%) 39 (68.4%) 1.00
Anemia 28 (100%) 50 (87.7%) 0.09
Steroids use 22 (78.6%) 40 (70.2%) 0.45
Renal problems 18 (64.3%) 25 (43.9%) 0.11
Liver problems 24 (85.7%) 41 (71.9%) 0.19
Preoperative FiO2 51.0 29.2 <0.001
Postoperative FiO2 36.9 30.7 <0.001

BPD bronchopulmonary dysplasia, CHD congenital heart disease, ORD other respiratory disorders, PHT pulmonary hypertension, PIG prolonged intubation group, RDS respiratory distress syndrome, SNIG short-no intubation group, P-values in bold indicate statistically significant results.